I agree that this site is using cookies. You can find further informations here.
X
Jhaveri, Komal L.
52  results:
Articles (Online) X
Search for persons X
?
1

Current and emerging treatment approaches for hormone recep..:

Jhaveri, Komal ; Marmé, Frederik
Cancer Treatment Reviews.  123 (2024)  - p. 102670 , 2024
Link: https://doi.org/10.1016/..
 
?
2

NVTG-07 SAFETY, TOLERABILITY, AND ANTITUMOR ACTIVITY OF TRA..:

Anders, Carey ; Loi, Sherene ; Hamilton, Erika...
Neuro-Oncology Advances.  6 (2024)  Supplement_1 - p. i25-i25 , 2024
Link: https://doi.org/10.1093/..
 
?
3

TROPION-Breast01: Datopotamab deruxtecan vs chemotherapy in..:

Bardia, Aditya ; Jhaveri, Komal ; Kalinsky, Kevin...
Future Oncology.  20 (2024)  8 - p. 423-436 , 2024
Link: https://doi.org/10.2217/..
 
?
4

Novel endocrine therapies: What is next in estrogen recepto..:

Corti, Chiara ; De Angelis, Carmine ; Bianchini, Giampaolo...
Cancer Treatment Reviews.  117 (2023)  - p. 102569 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Molecularly Targeted Therapies for Triple Negative Breast C..:

Mai, Nicholas ; Abuhadra, Nour ; Jhaveri, Komal
Clinical Breast Cancer.  23 (2023)  8 - p. 784-799 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Antitumour activity of neratinib in patients with HER2-muta..:

Harding, James J. ; Piha-Paul, Sarina A. ; Shah, Ronak H....
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
7

Matching-adjusted indirect comparison of PFS and OS compari..:

Jhaveri, Komal ; O'Shaughnessy, Joyce ; Fasching, Peter A....
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. , 2023
Link: https://doi.org/10.1177/..
 
?
8

Quality of life with ribociclib versus abemaciclib as first..:

Rugo, Hope S. ; Harmer, Victoria ; O'Shaughnessy, Joyce...
Therapeutic Advances in Medical Oncology.  15 (2023)  - p. 175883592311528 , 2023
Link: https://doi.org/10.1177/..
 
?
9

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Lutein..:

Jhaveri, Komal L. ; Bellet, Meritxell ; Turner, Nicholas C....
Clinical Cancer Research.  30 (2023)  4 - p. 754-766 , 2023
Link: https://doi.org/10.1158/..
 
?
10

Overall survival with sacituzumab govitecan in hormone rece..:

Rugo, Hope S ; Bardia, Aditya ; Marmé, Frederik...
The Lancet.  402 (2023)  10411 - p. 1423-1433 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Accelerating drug development in breast cancer: New frontie..:

Ferraro, Emanuela ; Walsh, Elaine M. ; Tao, Jacqueline J...
Cancer Treatment Reviews.  109 (2022)  - p. 102432 , 2022
Link: https://doi.org/10.1016/..
 
?
12

The Oncogenic PI3K-Induced Transcriptomic Landscape Reveals..:

Ladewig, Erik ; Michelini, Flavia ; Jhaveri, Komal...
Cancer Research.  82 (2022)  12 - p. 2269-2280 , 2022
Link: https://doi.org/10.1158/..
 
?
13

The oral selective estrogen receptor degrader GDC-0810 (ARN..:

Bardia, Aditya ; Mayer, Ingrid ; Winer, Eric...
Breast Cancer Research and Treatment.  197 (2022)  2 - p. 319-331 , 2022
Link: https://doi.org/10.1007/..
 
?
14

Characterization, management, and risk factors of hyperglyc..:

Liu, Dazhi ; Weintraub, Michael A. ; Garcia, Christine...
Cancer Medicine.  11 (2022)  8 - p. 1796-1804 , 2022
Link: https://doi.org/10.1002/..
 
?
15

Abemaciclib in Combination With Endocrine Therapy for Patie..:

Tolaney, Sara M. ; Beeram, Muralidhar ; Beck, J. Thaddeus...
Frontiers in Oncology.  11 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
1-15